Maxcyte (MXCT) EBIT Margin Growth (1y) (2021 - 2026)
Maxcyte (MXCT) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -361.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 102.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 241.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 851.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -313.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 535.00 |
| 10 | Maxcyte | 127.72 Mn | 127.72 Mn | 8.08 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Dec 31, 2025 | -99,810.00 |
| Sep 30, 2025 | -3,506.00 |
| Jun 30, 2025 | -319.00 |
| Mar 31, 2025 | 574.00 |
| Dec 31, 2024 | 51,203.00 |
| Sep 30, 2024 | 16,357.00 |
| Jun 30, 2024 | -9,653.00 |
| Mar 31, 2024 | 4,565.00 |
| Dec 31, 2023 | -38,870.00 |
| Sep 30, 2023 | -22,788.00 |
| Jun 30, 2023 | -5,361.00 |
| Mar 31, 2023 | -22,958.00 |
| Dec 31, 2022 | -980.00 |
| Sep 30, 2022 | -6,427.00 |
| Jun 30, 2022 | -2,881.00 |
| Mar 31, 2022 | 11,445.00 |
| Dec 31, 2021 | 50,938.00 |
| Sep 30, 2021 | 1,732.00 |
| Jun 30, 2021 | 6,014.00 |